Patient

For the purpose of risk minimisation, an individual using or considering the use of a medicinal product (including (healthy) individuals using vaccines and other medicinal products not intended to treat or alleviate a disease) as well as the embryo/foetus/child who may be adversely affected by a medicinal product at conception, in utero or through breastfeeding, and an individual who may be adversely affected through occupational, accidental or illegal13 exposure to a medicinal product, and also a parent, other carer and patient and consumer representative or organisation, as they may also be target populations of RMM.